Jackson Creek Investment Advisors LLC acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,888 shares of the company’s stock, valued at approximately $409,000.
A number of other hedge funds also recently bought and sold shares of the company. Van ECK Associates Corp purchased a new stake in DocuSign during the fourth quarter valued at $1,871,000. Mitchell Mcleod Pugh & Williams Inc. purchased a new stake in DocuSign during the fourth quarter valued at $208,000. Gilbert & Cook Inc. increased its position in DocuSign by 7.7% during the fourth quarter. Gilbert & Cook Inc. now owns 8,497 shares of the company’s stock valued at $505,000 after acquiring an additional 604 shares during the last quarter. PGGM Investments increased its position in DocuSign by 27.3% during the fourth quarter. PGGM Investments now owns 4,659 shares of the company’s stock valued at $277,000 after acquiring an additional 1,000 shares during the last quarter. Finally, Schwarz Dygos Wheeler Investment Advisors LLC purchased a new stake in DocuSign during the fourth quarter valued at $396,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Insider Transactions at DocuSign
In related news, insider Stephen Shute sold 15,109 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $57.02, for a total transaction of $861,515.18. Following the completion of the transaction, the insider now directly owns 8,959 shares of the company’s stock, valued at $510,842.18. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, insider Stephen Shute sold 15,109 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $57.02, for a total transaction of $861,515.18. Following the completion of the transaction, the insider now directly owns 8,959 shares of the company’s stock, valued at $510,842.18. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Peter Solvik sold 15,000 shares of the stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total value of $900,000.00. Following the transaction, the director now directly owns 783 shares of the company’s stock, valued at $46,980. The disclosure for this sale can be found here. Insiders sold a total of 54,871 shares of company stock valued at $3,176,199 over the last 90 days. Company insiders own 17.80% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on DOCU
DocuSign Stock Down 0.9 %
NASDAQ DOCU opened at $56.60 on Wednesday. The firm has a market cap of $11.63 billion, a price-to-earnings ratio of 157.23, a price-to-earnings-growth ratio of 4.94 and a beta of 0.89. The business has a 50-day moving average price of $56.76 and a 200-day moving average price of $53.03. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $64.76.
DocuSign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings data on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.06. The firm had revenue of $712.39 million during the quarter, compared to analyst estimates of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. Research analysts expect that DocuSign, Inc. will post 0.87 EPS for the current fiscal year.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- How to Invest in Insurance Companies: A Guide
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
- 3 Warren Buffett Stocks to Buy Now
- 5 Aerospace & Defense Stocks Ready for Liftoff
- How to Most Effectively Use the MarketBeat Earnings Screener
- Goldman Boosted FMC Stock’s Price Targets, Setting Up a Breakout
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.